Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Longitudinal changes of cortical microstructure in Parkinson's disease assessed with T1 relaxometry

L. Nürnberger, RM. Gracien, P. Hok, SM. Hof, U. Rüb, H. Steinmetz, R. Hilker, JC. Klein, R. Deichmann, S. Baudrexel,

. 2017 ; 13 (-) : 405-414. [pub] 20161221

Language English Country Netherlands

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc18016792

Grant support
NV16-30210A MZ0 CEP Register

BACKGROUND: Histological evidence suggests that pathology in Parkinson's disease (PD) goes beyond nigrostriatal degeneration and also affects the cerebral cortex. Quantitative MRI (qMRI) techniques allow the assessment of changes in brain tissue composition. However, the development and pattern of disease-related cortical changes have not yet been demonstrated in PD with qMRI methods. The aim of this study was to investigate longitudinal cortical microstructural changes in PD with quantitative T1 relaxometry. METHODS: 13 patients with mild to moderate PD and 20 matched healthy subjects underwent high resolution T1 mapping at two time points with an interval of 6.4 years (healthy subjects: 6.5 years). Data from two healthy subjects had to be excluded due to MRI artifacts. Surface-based analysis of cortical T1 values was performed with the FreeSurfer toolbox. RESULTS: In PD patients, a widespread decrease of cortical T1 was detected during follow-up which affected large parts of the temporo-parietal and occipital cortices and also frontal areas. In contrast, age-related T1 decrease in the healthy control group was much less pronounced and only found in lateral frontal, parietal and temporal areas. Average cortical T1 values did not differ between the groups at baseline (p = 0.17), but were reduced in patients at follow-up (p = 0.0004). Annualized relative changes of cortical T1 were higher in patients vs. healthy subjects (patients: - 0.72 ± 0.64%/year; healthy subjects: - 0.17 ± 0.41%/year, p = 0.007). CONCLUSIONS: In patients with PD, the development of widespread changes in cortical microstructure was observed as reflected by a reduction of cortical T1. The pattern of T1 decrease in PD patients exceeded the normal T1 decrease as found in physiological aging and showed considerable overlap with the pattern of cortical thinning demonstrated in previous PD studies. Therefore, cortical T1 might be a promising additional imaging marker for future longitudinal PD studies. The biological mechanisms underlying cortical T1 reductions remain to be further elucidated.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016792
003      
CZ-PrNML
005      
20180515103510.0
007      
ta
008      
180515s2017 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.nicl.2016.12.025 $2 doi
035    __
$a (PubMed)28116233
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Nürnberger, Lucas $u Department of Neurology, Goethe University, Frankfurt/Main, Germany; Brain Imaging Center, Goethe University, Frankfurt/Main, Germany.
245    10
$a Longitudinal changes of cortical microstructure in Parkinson's disease assessed with T1 relaxometry / $c L. Nürnberger, RM. Gracien, P. Hok, SM. Hof, U. Rüb, H. Steinmetz, R. Hilker, JC. Klein, R. Deichmann, S. Baudrexel,
520    9_
$a BACKGROUND: Histological evidence suggests that pathology in Parkinson's disease (PD) goes beyond nigrostriatal degeneration and also affects the cerebral cortex. Quantitative MRI (qMRI) techniques allow the assessment of changes in brain tissue composition. However, the development and pattern of disease-related cortical changes have not yet been demonstrated in PD with qMRI methods. The aim of this study was to investigate longitudinal cortical microstructural changes in PD with quantitative T1 relaxometry. METHODS: 13 patients with mild to moderate PD and 20 matched healthy subjects underwent high resolution T1 mapping at two time points with an interval of 6.4 years (healthy subjects: 6.5 years). Data from two healthy subjects had to be excluded due to MRI artifacts. Surface-based analysis of cortical T1 values was performed with the FreeSurfer toolbox. RESULTS: In PD patients, a widespread decrease of cortical T1 was detected during follow-up which affected large parts of the temporo-parietal and occipital cortices and also frontal areas. In contrast, age-related T1 decrease in the healthy control group was much less pronounced and only found in lateral frontal, parietal and temporal areas. Average cortical T1 values did not differ between the groups at baseline (p = 0.17), but were reduced in patients at follow-up (p = 0.0004). Annualized relative changes of cortical T1 were higher in patients vs. healthy subjects (patients: - 0.72 ± 0.64%/year; healthy subjects: - 0.17 ± 0.41%/year, p = 0.007). CONCLUSIONS: In patients with PD, the development of widespread changes in cortical microstructure was observed as reflected by a reduction of cortical T1. The pattern of T1 decrease in PD patients exceeded the normal T1 decrease as found in physiological aging and showed considerable overlap with the pattern of cortical thinning demonstrated in previous PD studies. Therefore, cortical T1 might be a promising additional imaging marker for future longitudinal PD studies. The biological mechanisms underlying cortical T1 reductions remain to be further elucidated.
650    _2
$a senioři $7 D000368
650    _2
$a mozková kůra $x diagnostické zobrazování $7 D002540
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a longitudinální studie $7 D008137
650    _2
$a magnetická rezonanční tomografie $x metody $7 D008279
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a Parkinsonova nemoc $x diagnostické zobrazování $7 D010300
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Gracien, René-Maxime $u Department of Neurology, Goethe University, Frankfurt/Main, Germany; Brain Imaging Center, Goethe University, Frankfurt/Main, Germany.
700    1_
$a Hok, Pavel $u Department of Neurology, Goethe University, Frankfurt/Main, Germany; Brain Imaging Center, Goethe University, Frankfurt/Main, Germany; Department of Neurology, Palacky University, Olomouc, Czech Republic.
700    1_
$a Hof, Stephanie-Michelle $u Department of Neurology, Goethe University, Frankfurt/Main, Germany; Brain Imaging Center, Goethe University, Frankfurt/Main, Germany.
700    1_
$a Rüb, Udo $u Dr. Senckenberg Chronomedical Institute, Goethe University, Frankfurt/Main, Germany.
700    1_
$a Steinmetz, Helmuth $u Department of Neurology, Goethe University, Frankfurt/Main, Germany.
700    1_
$a Hilker, Rüdiger $u Department of Neurology, Goethe University, Frankfurt/Main, Germany; Brain Imaging Center, Goethe University, Frankfurt/Main, Germany.
700    1_
$a Klein, Johannes C $u Department of Neurology, Goethe University, Frankfurt/Main, Germany; Brain Imaging Center, Goethe University, Frankfurt/Main, Germany; Nuffield Department of Clinical Neurosciences, University of Oxford, UK.
700    1_
$a Deichmann, Ralf $u Brain Imaging Center, Goethe University, Frankfurt/Main, Germany.
700    1_
$a Baudrexel, Simon $u Department of Neurology, Goethe University, Frankfurt/Main, Germany; Brain Imaging Center, Goethe University, Frankfurt/Main, Germany.
773    0_
$w MED00188130 $t NeuroImage. Clinical $x 2213-1582 $g Roč. 13, č. - (2017), s. 405-414
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28116233 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180515103644 $b ABA008
999    __
$a ok $b bmc $g 1300416 $s 1013632
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 13 $c - $d 405-414 $e 20161221 $i 2213-1582 $m NeuroImage. Clinical $n Neuroimage Clin $x MED00188130
GRA    __
$a NV16-30210A $p MZ0
LZP    __
$a Pubmed-20180515

Find record

Citation metrics

Archiving options